Anti-CXCR4 antibody and its use for the detection and diagnosis of cancer
US9518120B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2012 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | Aug 2, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a novel, isolated anti-CXCR4 antibody for use in the diagnosis of cancer. In particular, the antibody of the invention recognizes monomeric and homodimeric CXCR4, but not heterodimeric CXCR4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.